Identification of OTC pharma business acquisition opportunity and advice to the buyer

Identification that the human OTC business of the French veterinary group Dômes Pharma was non-core and originating negotiations with Schaer Pharma who we advsided throughout the whole process. After a share deal collapsed in December 2017 an asset deal was closed in June 2018.